MedPath

Upper Limit for TSH of First and Second Trimester Pregnancy in Turkey

Conditions
Pregnancy Early
Thyroid
Thyroid Dysfunction
Hypothyroidism
Interventions
Diagnostic Test: Serum thyroid functions tests
Registration Number
NCT03754621
Lead Sponsor
Bartin State Hospital
Brief Summary

Physiological changes necessitate the use of pregnancy-specific reference ranges for TSH and FT4 to diagnose thyroid dysfunction during pregnancy. Although many centers use fixed upper limits for TSH of 2.5 or 3.0 mU/L, this may lead to overdiagnosis or even overtreatment.

The new guidelines of the American Thyroid Association have considerably changed recommendations regarding thyroid function reference ranges in pregnancy accordingly. Any hospital or physician that is still using the 2.5 or 3.0 mU/l cut-off for TSH during pregnancy should evaluate their own lab-specific cut-offs.

The investigator's objective is to establish a rational reference range of serum TSH for diagnosis of subclinical hypothyroidism in the first and second trimester of pregnant women in west Black Sea region in Turkey.

Detailed Description

Serum thyroid function tests (including T3, T4, TSH, Anti-TPO) will be obtained from the singleton pregnancies in first and second trimester to determine the local specific normal ranges.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
400
Inclusion Criteria
  • Singleton pregnancy
  • Free of pre-existing thyroid disease
  • That do not use thyroid interfering medication
  • That did not undergo IVF treatment
  • TPOAb negative
Exclusion Criteria
  • Adolescent pregnancy

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
PregnantsSerum thyroid functions tests400 pregnant women with a singleton pregnancy, free of pre-existing thyroid disease, that do not use thyroid interfering medication, that did not undergo IVF treatment and are TPOAb negative. Serum thyroid functions tests will be obtained on the first visit.
Primary Outcome Measures
NameTimeMethod
TSHDay 1

Serum TSH (mU/I)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Bartin State Hospital

🇹🇷

Bartin, Turkey

© Copyright 2025. All Rights Reserved by MedPath